HomeCompareTBRIF vs NOBL

TBRIF vs NOBL: Dividend Comparison 2026

TBRIF yields 5263.16% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBRIF wins by $102432968530093.41M in total portfolio value
10 years
TBRIF
TBRIF
● Live price
5263.16%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102432968530093.42M
Annual income
$98,742,385,398,383,070,000.00
Full TBRIF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — TBRIF vs NOBL

📍 TBRIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBRIFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBRIF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBRIF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBRIF
Annual income on $10K today (after 15% tax)
$447,368.42/yr
After 10yr DRIP, annual income (after tax)
$83,931,027,588,625,610,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, TBRIF beats the other by $83,931,027,588,625,610,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBRIF + NOBL for your $10,000?

TBRIF: 50%NOBL: 50%
100% NOBL50/50100% TBRIF
Portfolio after 10yr
$51216484265046.72M
Annual income
$49,371,192,699,191,530,000.00/yr
Blended yield
96.40%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBRIF buys
0
NOBL buys
0
No recent congressional trades found for TBRIF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBRIFNOBL
Forward yield5263.16%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$102432968530093.42M$22.8K
Annual income after 10y$98,742,385,398,383,070,000.00$246.19
Total dividends collected$102183681196311.97M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: TBRIF vs NOBL ($10,000, DRIP)

YearTBRIF PortfolioTBRIF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$537,016$526,315.79$10,914$214.34+$526.1KTBRIF
2$26,989,550$26,414,942.92$11,897$218.63+$26.98MTBRIF
3$1,269,600,822$1,240,722,003.32$12,952$222.72+$1269.59MTBRIF
4$55,904,391,573$54,545,918,693.73$14,086$226.62+$55904.38MTBRIF
5$2,304,512,049,686$2,244,694,350,703.24$15,302$230.33+$2304512.03MTBRIF
6$88,943,998,518,419$86,478,170,625,254.53$16,607$233.85+$88943998.50MTBRIF
7$3,214,493,329,356,589$3,119,323,250,941,881.00$18,007$237.18+$3214493329.34MTBRIF
8$108,798,712,659,598,690$105,359,204,797,187,140.00$19,508$240.35+$108798712659.58MTBRIF
9$3,449,143,113,747,977,000$3,332,728,491,202,206,700.00$21,116$243.35+$3449143113747.96MTBRIF
10$102,432,968,530,093,420,000$98,742,385,398,383,070,000.00$22,841$246.19+$102432968530093.41MTBRIF

TBRIF vs NOBL: Complete Analysis 2026

TBRIFStock

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.

Full TBRIF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this TBRIF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBRIF vs SCHDTBRIF vs JEPITBRIF vs OTBRIF vs KOTBRIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.